Literature DB >> 9129080

Interaction of human mannose-binding protein with Mycobacterium avium.

V Y Polotsky1, J T Belisle, K Mikusova, R A Ezekowitz, K A Joiner.   

Abstract

The interaction between human mannose-binding protein (MBP) and Mycobacterium avium was explored. By ELISA, calcium-dependent and mannan-inhibitable binding of human recombinant MBP (rMBP) to live M. avium was observed. Preincubation of M. avium with rMBP resulted in a 2-fold increase in uptake by human neutrophils. Mycobacterial cell wall components were assessed by ELISA for their ability to bind the carbohydrate recognition domain of rMBP. The best ligand was mannosyl-lipoarabinomannan, followed by lipomannan, phosphatidylinositol mannoside, arabinosyl-lipoarabinomannan, and dimycolated trehalose (cord factor). rMBP did not bind to partially purified lipid fractions containing glycopeptidolipids. These results are consistent with the known structural basis for rMBP ligand recognition. They suggest that MBP may play a role in host defense against M. avium by opsonizing both whole organisms and free cell wall components for internalization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129080     DOI: 10.1086/520354

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

3.  The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms.

Authors:  M Devyatyarova-Johnson; I H Rees; B D Robertson; M W Turner; N J Klein; D L Jack
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 4.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.

Authors:  M A Bartlomiejczyk; A S Swierzko; A Brzostek; J Dziadek; M Cedzynski
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 7.  The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis.

Authors:  Rainer Kalscheuer; Ainhoa Palacios; Itxaso Anso; Javier Cifuente; Juan Anguita; William R Jacobs; Marcelo E Guerin; Rafael Prados-Rosales
Journal:  Biochem J       Date:  2019-07-18       Impact factor: 3.857

8.  Mannose-binding lectin is present in human semen and modulates cellular adhesion of Neisseria gonorrhoeae in vitro.

Authors:  J B Wing; D L Jack; M E Lee; A A Pacey; G R Kinghorn; R C Read
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

9.  Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid.

Authors:  J Scott Ferguson; Jeremy J Weis; Jennifer L Martin; Larry S Schlesinger
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 10.  Mannose-binding lectin two gene polymorphisms and tuberculosis susceptibility in Chinese population: a meta-analysis.

Authors:  Jing Shi; Min Xie; Jian-Miao Wang; Yong-Jian Xu; Wei-Ning Xiong; Xian-Sheng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.